Sun Pharma announces positive results of two phase-III CTs of Tildrakizumab
The IL-23p19 Therapeutic Antibody meets primary endpoints in both placebo-controlled studies and secondary endpoint in…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.